Ulrich Mahlknecht
Ulrich Rudolph Mahlknecht (* 29. April 1967) is a German/Italian physician scientist.
Life
Ulrich Mahlknecht grew up in La Villa/Badia, which is located in South Tyrol (Italy), Alta Badia, Gadertal, Südtirol. He studied medicine at the University of Bochum, the University of Birmingham, the Paris-Sud 11 University and the University of Tübingen, where he received his medical doctorate in 1995. He received his postgraduate medical training in internal medicine at the University of Freiburg in Freiburg im Breisgau. From 1996 until 1999 Ulrich Mahlknecht was a graduate student at the Picower Graduate School of Molecular Medicine (State University of New York), where he was then employed as a postdoc and later as a senior scientist. He has actively published in cancer and HIV research, authoring several classic papers[1][2][3][4]. From 1999 until 2003 he received his specialist training in internal medicine and hematology/oncology at the Goethe University Frankfurt in Frankfurt am Main, where he became an assistant professor of internal medicine. From 2004 until 2007 he was an associate professor at the University Hospital Heidelberg where he was head of the acute leukemias and myelodysplastic syndromes task force. Ulrich Mahlknecht was founder of the Heidelberg excellence center for myelodysplastic syndromes.
Ulrich Mahlknecht was a scholar within a Deutsche Forschungsgemeinschaft young investigator excellence reserach program (Emmy Noether-Program). His reserach was later also supported by the Deutsche José Carreras Leukemia Foundation. In 2007 Ulrich Mahlknecht became a full professor of medicine at the Saarland University, where he is currently head of the Division of Immunotherapy and Gene Therapy within the Department of Internal Medicine. Ulrich Mahlknecht is president of the Clinical Epigenetics Society (CLEPSO), a non-for-profit international organization, which supports basic, translational and clinical research within the field of epigenetics. In 2009 Ulrich Mahlknecht founded and became editor-in-chief of the Clinical Epigenetics journal
Weblinks
- [http://www.mahlknecht-lab.de Ulrich Mahlknecht's lab at the Saarland University
- [http://www.clinical-epigenetics-society.org the Clinical Epigenetics Society (CLEPSO)
- [http://www.springer.com/biomed/human+genetics/journal/13148 Clinical Epigenetics
References
- ^ Mahlknecht U, Emiliani S, Najfeld V, Young S, Verdin E (1999). "Genomic organization and chromosomal localization of the human histone deacetylase 3 gene". Genomics. 56 (2): 197–202. doi:10.1006/geno.1998.5645. PMID 10051405.
{{cite journal}}: Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link) - ^ Mahlknecht U, Ottmann OG, Hoelzer D (2000). "When the band begins to play: histone acetylation caught in the crossfire of gene control". Mol. Carcinog. 27 (4): 268–71. PMID 10747290.
{{cite journal}}: Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link) - ^ Herbein G, Mahlknecht U, Batliwalla F; et al. (1998). "Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4". Nature. 395 (6698): 189–94. doi:10.1038/26026. PMID 9744279.
{{cite journal}}: Explicit use of et al. in:|author=(help); Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link) - ^ Mahlknecht U, Deng C, Lu MC; et al. (2000). "Resistance to apoptosis in HIV-infected CD4+ T lymphocytes is mediated by macrophages: role for Nef and immune activation in viral persistence". J. Immunol. 165 (11): 6437–46. PMID 11086083.
{{cite journal}}: Explicit use of et al. in:|author=(help); Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link)